1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2025PM exposure during pregnancy affects childhood asthma via placental epigenetic changes: Neuronal differentiation and proliferation and Notch signaling pathwaysENVIRONMENTAL POLLUTION
2024Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapyJOURNAL OF GYNECOLOGIC ONCOLOGY
2024From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps CANCERS
2024Pembrolizumab or Placebo With Chemoradiotherapy Followed by Pembrolizumab or Placebo for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): A Randomized, Double-Blind, Phase 3 Clinical TrialOBSTETRICAL & GYNECOLOGICAL SURVEY
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
2024Unique immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8 + TILs based on BRCA1/2 mutation status in epithelial ovarian cancers JOURNAL FOR IMMUNOTHERAPY OF CANCER
2024Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical CancerNEW ENGLAND JOURNAL OF MEDICINE
2024Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001)EJSO
2024Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial JOURNAL OF CLINICAL ONCOLOGY
2024Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysisGYNECOLOGIC ONCOLOGY
2024Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease NUTRIENTS
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trialLANCET
2024Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trialGYNECOLOGIC ONCOLOGY
2024Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial JOURNAL OF CLINICAL ONCOLOGY
2024Prenatal Diagnosis and Clinical Outcomes of Isolated Mega Cisterna MagnaJOURNAL OF CHILD NEUROLOGY
2024Decision-making process for risk-reducing salpingo-oophorectomy among Korean women with hereditary breast cancer: A grounded theory studyEUROPEAN JOURNAL OF ONCOLOGY NURSING
2024Factors affecting the technical outcome of catheter-directed sclerotherapy for ovarian endometriomasEUROPEAN JOURNAL OF RADIOLOGY
2024Efficacy of large language models and their potential in Obstetrics and Gynecology education Obstetrics & Gynecology Science

Recent Submissions

Browse

Links